We are live on ! Find out more
ET

Entropy Technologies Portfolio holdings

AUM $2.17B
1-Year Est. Return 21.46%
This Fund
S&P 500
This Quarter Est. Return
+0.83%
1 Year Est. Return
+21.46%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$971M
AUM Growth
+$18.5M
Cap. Flow
+$42.1M
Cap. Flow %
4.33%
Top 10 Hldgs %
11.2%
Holding
1,053
New
366
Increased
178
Reduced
145
Closed
362

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$12M
2
KLAC icon
KLA
KLAC
+$10.9M
3
LOW icon
Lowe's Companies
LOW
+$8.78M
4
CDW icon
CDW
CDW
+$8.59M
5
NVDA icon
NVIDIA
NVDA
+$8.53M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$12.6M
2
SHW icon
Sherwin-Williams
SHW
+$8.64M
3
APP icon
Applovin
APP
+$8.38M
4
MSFT icon
Microsoft
MSFT
+$8.36M
5
USB icon
US Bancorp
USB
+$7.8M

Sector Composition

Rank Sector Weight
1 Technology 18.52%
2 Financials 14.59%
3 Industrials 12.34%
4 Healthcare 12.24%
5 Consumer Discretionary 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNC icon
576
Lincoln National
LNC
$8.19B
$258K 0.03%
8,121
-17,603
-68% -$587K
ALC icon
577
Alcon
ALC
$33.7B
$257K 0.03%
+3,032
New +$273K
FSK icon
578
FS KKR Capital
FSK
$3.08B
$257K 0.03%
+11,836
New +$248K
MGA icon
579
Magna International
MGA
$18.8B
$256K 0.03%
+6,116
New +$263K
RYN icon
580
Rayonier
RYN
$6.64B
$254K 0.03%
10,220
-1,342
-12% -$37.4K
RMD icon
581
ResMed
RMD
$30.3B
$249K 0.03%
1,089
-6,581
-86% -$1.58M
COO icon
582
Cooper Companies
COO
$14.1B
$248K 0.03%
+2,700
New +$275K
INVA icon
583
Innoviva
INVA
$1.61B
$248K 0.03%
+14,298
New +$275K
GSHD icon
584
Goosehead Insurance
GSHD
$1.64B
$247K 0.03%
+2,306
New +$252K
BLBD icon
585
Blue Bird Corp
BLBD
$2.34B
$245K 0.03%
6,352
-700
-10% -$29.2K
AAP icon
586
Advance Auto Parts
AAP
$3.54B
$244K 0.03%
+5,169
New +$210K
MRX
587
Marex Group Limited Ordinary Shares
MRX
$4.62B
$243K 0.03%
+7,800
New +$218K
MEOH icon
588
Methanex
MEOH
$4.12B
$240K 0.02%
+4,800
New +$211K
SCL icon
589
Stepan Co
SCL
$1.32B
$239K 0.02%
+3,700
New +$274K
WFC icon
590
Wells Fargo
WFC
$263B
$239K 0.02%
+3,400
New +$232K
DOX icon
591
Amdocs
DOX
$5.83B
$238K 0.02%
+2,800
New +$246K
NSP icon
592
Insperity
NSP
$2.01B
$238K 0.02%
3,065
-2,015
-40% -$163K
CBT icon
593
Cabot Corp
CBT
$4.7B
$237K 0.02%
2,595
-3,680
-59% -$395K
PRMB
594
Primo Brands
PRMB
$8.54B
$236K 0.02%
+7,665
New +$227K
SYK icon
595
Stryker
SYK
$133B
$236K 0.02%
+655
New +$243K
DUOL icon
596
Duolingo
DUOL
$6.56B
$235K 0.02%
726
-100
-12% -$31.8K
CACC icon
597
Credit Acceptance
CACC
$5.84B
$235K 0.02%
+500
New +$232K
TPB icon
598
Turning Point Brands
TPB
$1.56B
$234K 0.02%
+3,900
New +$208K
BCE icon
599
BCE
BCE
$20.3B
$232K 0.02%
10,002
-43,897
-81% -$1.26M
OBDE
600
DELISTED
Blue Owl Capital Corporation III
OBDE
$232K 0.02%
+16,077
New +$237K

Similar funds

Entropy Technologies's Q4 2024 Portfolio in Review

As of Q4 2024, Entropy Technologies held 1,053 positions worth $971M, up 1.9% from $952M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Entropy Technologies deployed $42.1M of net new capital in Q4 2024, opening 366 new positions and adding to 178 existing holdings. Its largest new stake was KLA: 161,190 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Applovin, an estimated $8.38M trimmed.

  • Entropy Technologies's largest Q4 2024 buy was KLA: 161,190 shares worth $10.2M.
  • Entropy Technologies added most to Pfizer in Q4 2024, an estimated $12M increase.
  • Entropy Technologies's biggest Q4 2024 reduction was Applovin, cutting an estimated $8.38M.
  • Entropy Technologies fully exited Lam Research in Q4 2024, selling an estimated $12.6M.
  • Entropy Technologies's ten largest holdings make up 11% of its $971M portfolio in Q4 2024.
  • Entropy Technologies opened 366 new positions and closed 362 in Q4 2024.
  • Entropy Technologies's portfolio value rose 1.9% quarter-over-quarter to $971M.

Based on Entropy Technologies's 13F filing for Q4 2024, filed 28 Jan 2025.